Anavex Life Sciences Corp (AVXL)

[anders2211]

The patent (No. 10,507,196) is valid until at least 2037 and also covers methods of treatment based on Anavex 2-73 for other disorders including multiple sclerosis, Angleman Syndrom, Cerebral Palsy and Autism spectrum disorders

As a parent of a mid severely classic autistic boy (7) I deeply hope that 273 will treat or relieve or improve the symptoms of autism. However, technically I don't understand the US patent for autism. Medical technical autism is not if you will a disease or condition but its a collection name of behavioral symptoms one can observe we now call ASD. Fragile X is an autism disorder that one medically technical can observe in the genes. One can only treat which one can medically observe in genes or DNA or TAU with Alzheimer etc. There are many forms of autism one different than the other observable in the genes of kids and there are many kids where (since only 55% of the genes can be mapped) nothing can be observed (as with my son). Therefore my question is. Why grant a patent to a collection name which resembles a type of behavior but technical, is not a disease or gene dysfunction?

Anyone?